Overview

Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this thirteen-week, open-label study is to test the hypothesis that quetiapine in combination with Oros methylphenidate will reduce aggressive symptoms in children and adolescents who have shown inadequate response to OROS methylphenidate alone.
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University School of Medicine
Treatments:
Methylphenidate
Quetiapine Fumarate